This report highlights recently published research examining how genetic variation in aquaporin-4 (AQP4) may relate to Alzheimer’s disease-related brain and cognitive changes, and whether these relationships are influenced by sleep.
AQP4 is a water channel protein located primarily in astrocytes and is thought to play an important role in brain fluid regulation and glymphatic clearance. The study analyzed cognitively unimpaired older adults with evidence of amyloid beta accumulation and combined genetic data with sleep measures, brain imaging, and cognitive assessments.
Researchers found that specific AQP4 genetic variants were associated with differences in cognition and brain structure. Several of these associations also varied according to sleep duration, sleep onset latency, sleep disturbances, and overall sleep quality.
The findings provide further evidence that AQP4-related genetic variation may be linked to Alzheimer’s disease phenotypes and suggest that sleep may act as an important modifier of these relationships. Further longitudinal and interventional studies are needed to determine whether these associations are causal.
- AQP4 genetic variation was associated with differences in cognition and brain structure in older adults at increased risk of Alzheimer’s disease.
- One AQP4 variant, rs162007, was associated with better cross-sectional cognitive performance.
- Sleep duration interacted with specific AQP4 variants in relation to gray matter atrophy and white matter volume.
- Sleep onset latency and overall sleep quality were associated with genotype-dependent differences in ventricular volume.
- Sleep disturbances interacted with AQP4 variants in relation to differences in cognitive decline over time.
- The findings support a broader relationship between AQP4 genetic variation and Alzheimer’s-related phenotypes, with sleep acting as a potential modifier.
Access the full peer-reviewed publication describing the relationships between aquaporin-4 genetic variants, sleep characteristics, brain structure, amyloid beta accumulation, and cognitive outcomes in older adults at increased risk of Alzheimer’s disease.
View Full Publication